The grey zone of thyroid function: Clinical significance and management controversies in subclinical hypothyroidism
SA Pharmaceutical Journal · 01.04.2026 · 93 (2) · 29-37
DOI: 10.36303/sapj.4384 ↗Kurz gefasst
Fachartikel in der Zeitschrift SA Pharmaceutical Journal, erschienen am 01.04.2026. Verfasst von OA Omoteso und 6 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Omoteso, O., Sibanda, U., Zhou, A., Melamane, S., Sibiya, N., Ndzamba, B., & Egunlusi, A. (2026). The grey zone of thyroid function: Clinical significance and management controversies in subclinical hypothyroidism. SA Pharmaceutical Journal, 93(2), 29-37. https://doi.org/10.36303/sapj.4384
Vancouver
Omoteso O, Sibanda U, Zhou A, Melamane S, Sibiya N, Ndzamba B, et al. The grey zone of thyroid function: Clinical significance and management controversies in subclinical hypothyroidism. SA Pharmaceutical Journal. 2026;93(2):29-37. doi:10.36303/sapj.4384
BibTeX
@article{Omoteso2026,
author = {Omoteso, OA and Sibanda, UM and Zhou, A and Melamane, S and Sibiya, N and Ndzamba, B and Egunlusi, AO},
title = {The grey zone of thyroid function: Clinical significance and management controversies in subclinical hypothyroidism},
journal = {SA Pharmaceutical Journal},
year = {2026},
volume = {93},
number = {2},
pages = {29--37},
doi = {10.36303/sapj.4384}
}
EUVIMED